Cell culture media is a nutrient-rich solution used to grow and maintain cell cultures. It typically contains a variety of components, such as amino acids, vitamins, salts, proteins, carbohydrates, and other substances. The exact composition of a cell culture medium will vary depending on the type of cells and the desired results. Common components of cell culture media include fetal bovine serum (FBS), antibiotics, growth factors, and buffering agents. Additionally, some cell culture media may also contain additional components such as dyes, preservatives, or hormones.
Currently, global cell culture media market size is projected to USD 10.3 billion by 2026, at a CAGR of 16.0%. The growth of this market is majorly driven by the rising RD spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, expensive cell biology research products and ethical concerns regarding cell biology research are expected to hinder the growth of this market.
Request for assumptions how numbers were triangulated.
https://www.marketsandmarkets.com/requestsampleNew.asp?id=97468536
Drivers:
In the pharmaceutical industry, cell culture has become a prominent part of vaccine production. The cell culture technology has been used to produce vaccines for rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox. Cell-based flu vaccines have also been approved for use in the US and many European countries.
Opportunities:
During the forecast period, emerging countries such as China, India, Brazil, and Mexico are expected to become the focal point for growth in the global market. Increasing investments in cell biology research and the rising focus of market players on increasing their presence in emerging Asian markets are the major factors responsible for this trend.
The prominent players operating in the cell culture media market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US)
Thermo Fisher Scientific (US) provides cell culture products, including cell culture media, through its Life Sciences Solutions and Specialty Diagnostics segments. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. From 2019 to 2021, Thermo Fisher launched 4 cell culture media products, including the Gibco CTS NK-Xpander Medium, Gibco Human Plasma-like Medium (HPLM), Gibco CTS OpTmizer Pro Serum-free Media (SFM), and Gibco BenchStable Media. With its strong product portfolio, continuous research and development activities, and broad geographic reach, Thermo Fisher Scientific is expected to witness significant growth in the market.
Danaher Corporation (US) conducts its business through three segments, namely, Life Sciences, Diagnostics, and Environmental Applied Solutions. The Life Sciences business segment offers cell culture media products under Cytiva. The company has a strong geographic presence with subsidiaries across North America, Europe, the Asia Pacific, Latin America, and Africa. Danaher also has a significant focus on strategic collaborations and acquisitions to strengthen its competitive position in the cell culture media market. For instance, in March 2020, Danaher completed the acquisition of General Electric’s Life Sciences Division and renamed it Cytiva to enhance its Life Sciences products and services portfolio.
Merck KGaA (Germany) operates through three business segments, namely, Healthcare, Life Science, and Performance Materials. The Life Science segment is further divided into research solutions, process solutions, and applied solutions subsegments. Merck provides cell culture media products through the research solutions and process solutions subsegments. Merck KGaA is one of the leading players in the cell culture media market. Its key strength lies in its strong product portfolio. The company adopts organic growth strategies such as expansions to increase its dominance in this market. In May 2019, the company completed the expansion to its Irvine biopharmaceutical production facility for the production of both powder and liquid cell culture media.
Download an Illustrative Overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536
The global market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of the global market, followed by Europe. The growing regulatory approvals for cell culture-based vaccines, growth in the biotechnology pharmaceutical industries, higher investments in cell-based research, and strong government support are the key factors driving the growth of the market in North America..
Recent Developments
- In October 2021, Thermo Fisher Scientific Inc. (US) launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
- In July 2021, Sartorius AG acquired cell culture specialist Xell AG thus expanding its capabilities for manufacturing dry powder and liquid media.
Content Source:
https://www.marketsandmarkets.com/Market-Reports/cell-culture-media-market-97468536.html
